Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01488396Phase 4Completed
A Phase 4 trial of cyclosporine 2% ophthalmic solution in Stevens-Johnson syndrome (SJS), sponsored by Mahidol University. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01488396.